文献速递冠心病

未治疗慢性阻塞性冠心病对TAVR结局的影响

Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
PubMed 文献 · Eur Heart J · 2024-01-01

该回顾性队列研究纳入2015年1月至2021年11月接受TAVR的1911例患者,按慢性阻塞性冠心病严重程度分组。结果显示未治疗慢性阻塞性CAD患者TAVR手术安全性良好,围术期并发症率低且组间无差异,随访21个月急性冠脉综合征和计划外血运重建率随CAD严重程度增加而升高,但多变量分析未显示全因死亡或主要不良心血管事件风险显著增加。

要点

  • 未治疗慢性阻塞性CAD患者TAVR围术期并发症率低,组间无差异
  • 随访21个月急性冠脉综合征和计划外血运重建率随CAD严重程度增加而升高
  • 多变量分析未显示全因死亡或主要不良心血管事件风险显著增加

核心结论

  • TAVR可在未治疗慢性阻塞性CAD患者中安全进行,不增加围术期并发症率,1年计划外血运重建和急性冠脉综合征率相对较低。

研究设计与样本

  • 回顾性队列研究,纳入2015年1月至2021年11月接受TAVR的1911例患者,按慢性阻塞性CAD严重程度分为非阻塞性、中危、高危和极高危组。

主要发现

  • 1911例患者中非阻塞性、中危、高危和极高危CAD分别占75%、6%、10%和9%。
  • 围术期并发症总体发生率低:死亡0.4%、休克0.1%、体外膜肺氧合0.1%,组间无差异。
  • 中位随访21个月,非阻塞性CAD患者急性冠脉综合征和计划外冠脉血运重建率分别为0.7%和0.5%,发生率随CAD严重程度增加而升高(P < .001)。
  • 多变量分析未显示各组全因死亡或主要不良心血管事件风险显著增加。
  • 1年时事件分析中,非阻塞性(98%)vs. 阻塞性(94%)亚组的急性冠脉综合征和计划外冠脉血运重建率显著更高(Plog-rank< .001)。

临床怎么用

  • 对于合并未治疗慢性阻塞性CAD的TAVR候选者,可考虑不常规进行血运重建而直接行TAVR,但需关注术后急性冠脉综合征和计划外血运重建风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In transcatheter aortic valve replacement (TAVR) recipients, the optimal management of concomitant chronic obstructive coronary artery disease (CAD) remains unknown. Some advocate for pre-TAVR percutaneous coronary intervention, while others manage it expectantly. The aim of this study was to assess the impact of varying degrees and extent of untreated chronic obstructive CAD on TAVR and longer-term outcomes. METHODS: The authors conducted a retrospective cohort study of TAVR recipients from January 2015 to November 2021, separating patients into stable non-obstructive or varying degrees of obstructive CAD. The major outcomes of interest were procedural all-cause mortality and complications, major adverse cardiovascular events, and post-TAVR unplanned coronary revascularization. RESULTS: Of the 1911 patients meeting inclusion, 75%, 6%, 10%, and 9% had non-obstructive, intermediate-risk, high-risk, and extreme-risk CAD, respectively. Procedural complication rates overall were low (death 0.4%, shock 0.1%, extracorporeal membrane oxygenation 0.1%), with no difference across groups. At a median follow-up of 21 months, rates of acute coronary syndrome and unplanned coronary revascularization were 0.7% and 0.5%, respectively, in the non-obstructive population, rising in incidence with increasing severity of CAD (P < .001 for acute coronary syndrome/unplanned coronary revascularization). Multivariable analysis did not yield a significantly greater risk of all-cause mortality or major adverse cardiovascular events across groups. One-year acute coronary syndrome and unplanned coronary revascularization rates in time-to-event analyses were significantly greater in the non-obstructive (98%) vs. obstructive (94%) subsets (Plog-rank< .001). CONCLUSIONS: Transcatheter aortic valve replacement can be performed safely in patients with untreated chronic obstructive CAD, without portending higher procedural complication rates and with relatively low rates of unplanned coronary revascularization and acute coronary syndrome at 1 year.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Persits, Layoun, Kondoleon, et al. Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement. Eur Heart J. 2024. PMID: 38270189. doi:10.1093/eurheartj/ehae019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。